Aakha Biologics Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $600K

  • Investors
  • 5

Aakha Biologics General Information

Description

Operator of a biotechnology research company intended to develop next-generation immunotherapies for cancer treatment. The company employs several advanced antibody discovery platforms and a synergistic approach to expedite the optimization, development, and production of therapeutic options, enabling scientists and drug developers to create life-saving therapies and progress from concept to investigational new drug-enabling studies.

Contact Information

Website
www.aakha.bio
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 5680 Frisco Square Boulevard
  • Suite 2100
  • Frisco, TX 75034
  • United States
+1 (617)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 5680 Frisco Square Boulevard
  • Suite 2100
  • Frisco, TX 75034
  • United States
+1 (617)

Aakha Biologics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aakha Biologics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Early Stage VC (Series A) 05-Aug-2026 $600K Completed Generating Revenue
4. Seed Round 17-Jul-2024 Completed Generating Revenue
3. Grant 22-May-2024 Completed Generating Revenue
2. Grant 22-May-2024 $2.55M $4.8M Completed Generating Revenue
1. Seed Round 15-Apr-2024 $4.8M $4.8M Completed Pre-Clinical Trials
To view Aakha Biologics’s complete valuation and funding history, request access »

Aakha Biologics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed-2
Seed-1
To view Aakha Biologics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Aakha Biologics Patents

Aakha Biologics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2024304442-A1 Mhc class i chain-related protein a (mica)-specific antibodies and uses thereof Pending 15-Jun-2023
EP-4727976-A2 Mhc class i chain-related protein a (mica)-specific antibodies and uses thereof Pending 15-Jun-2023
WO-2024259273-A2 Mhc class i chain-related protein a (mica)-specific antibodies and uses thereof Inactive 15-Jun-2023
WO-2024259273-A3 Mhc class i chain-related protein a (mica)-specific antibodies and uses thereof Inactive 15-Jun-2023 C07K16/2833

Aakha Biologics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Aakha Biologics Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
ACS BrightEdge Corporate Venture Capital Minority
Opus8 PE/Buyout Minority
Cancer Prevention and Research Institute of Texas Government
National Cancer Institute Government
Alloy Therapeutics VC-Backed Company Minority
To view Aakha Biologics’s complete investors history, request access »

Aakha Biologics FAQs

  • When was Aakha Biologics founded?

    Aakha Biologics was founded in 2021.

  • Where is Aakha Biologics headquartered?

    Aakha Biologics is headquartered in Frisco, TX.

  • What is the size of Aakha Biologics?

    Aakha Biologics has 8 total employees.

  • What industry is Aakha Biologics in?

    Aakha Biologics’s primary industry is Drug Discovery.

  • Is Aakha Biologics a private or public company?

    Aakha Biologics is a Private company.

  • What is Aakha Biologics’s current revenue?

    The current revenue for Aakha Biologics is .

  • How much funding has Aakha Biologics raised over time?

    Aakha Biologics has raised $6.15M.

  • Who are Aakha Biologics’s investors?

    ACS BrightEdge, Opus8, Cancer Prevention and Research Institute of Texas, National Cancer Institute, and Alloy Therapeutics have invested in Aakha Biologics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process